Tag Archives: Liberty Health Sciences

Aphria Liberty Health sale agreement

Liberty Health Sciences Applauds CSA Notice Regarding Issuers With U.S. Cannabis Investments

Liberty Health Sciences Applauds CSA Notice Regarding Issuers With U.S. Cannabis Investments

TORONTO, Ontario, Feb. 9, 2018 /Weed Wire/ – Liberty Health Sciences Inc. (CSE: LHS or US OTCQX: LHSIF) (the “Company” or “Liberty”) is providing the following statement in response to the Canadian Securities Administration’s (the “CSA”) Staff Notice 51-352 Issuers with U.S. Marijuana-Related Activities (the “Notice”), revised February 8, 2018.

Aphria Liberty Health sale agreement

Liberty Health Sciences Announces New Strategic Investors With Proven Investment Experience In Cannabis Industry

TORONTO, Ontario, Feb. 5, 2018 /Weed Wire/ — Liberty Health Sciences Inc. (CSE: LHS or US OTCBB: LHSIF) (the “Company” or “Liberty”) is pleased to announce today that a group of buyers led by members of the Serruya family (the “Group”) has entered into a purchase and sale agreement with Aphria Inc.

Aphria Liberty Health

Aphria Begins to Divest of its Equity Investment in Passive US Assets

LEAMINGTON, Ontario, Feb. 5, 2018 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX: APH or USOTCQB: APHQF) today announced that it entered into a purchase and sale agreement to sell 26,716,025 shares representing all its shares in Liberty Health Sciences Inc. (“Liberty”) that are not subject to Canadian Securities Exchange (“CSE”) escrow requirements.

Aphria Liberty Health sale agreement

Aphria And Liberty Health Sciences Announce Definitive Agreement For Sale Of Aphria’s Investment In Copperstate Farms To Liberty

LEAMINGTON AND TORONTO, Ontario, Feb. 2, 2018 /Weed Wire/ — Aphria Inc. (TSX:APH or OTCQB:APHQF) (“Aphria”) and Liberty Health Sciences Inc. (CSE:LHS or OTCQB:LHSIF) (“Liberty”) jointly announce that they have entered into a definitive agreement (the “Agreement”) with respect to the sale (the “Transaction”) of Aphria’s subsidiary Aphria (Arizona) Inc. and its sole holdings being the minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC (collectively “Copperstate”) to Liberty for a purchase price of $20 million (“Purchase Price”).

Aphria Liberty Health sale agreement

Liberty Health Sciences Opens Inaugural Medical Cannabis Dispensary in Florida in The Villages

TORONTO, Ontario, Jan. 16, 2018 /Weed Wire/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) announced today that it has opened its inaugural medical cannabis dispensary in Florida, strategically located in The Villages, the state’s largest retirement community.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Announces Proposed Acquisition of a 387 Acre Parcel of Land in Gainesville Including 200,000 Square Feet of Greenhouse and Processing Facilities

TORONTO, Ont., Jan. 4, 2018 /Weed Wire/ — Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”) announced today that it has entered into a binding term sheet to acquire all of the issued and outstanding shares of 242 Cannabis Canada Ltd. (the “242 Shares”), whose wholly-owned subsidiary 242 Cannabis, LLC, has agreed to purchase a 387 acre parcel of land in Gainesville, Florida (the “Property”).

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Announces Two Additional Dispensary Locations Have Been Secured In Florida

TORONTO, Ontario, Nov. 21, 2017 /Weed Wire/ — Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) announced today that it has secured locations for two additional medical cannabis dispensaries in the State of Florida that are scheduled to open in early 2018.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Signs Exclusive Licensing And Raw Materials Agreement With Mary’s Medicinals To Provide Floridians With Range Of Award-Winning Cannabis Products

TORONTO, Ontario, Oct. 24, 2017 /Weed Wire/ — Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) today announced a partnership with Colorado-based MM Technology Holdings, LLC (“Mary’s”) to bring its award-winning line of Mary’s Medicinals® cannabis products to the Florida market.

Shares of Canada's Aphria Slump as Marijuana Faces Regulatory Risk

Shares of Canada’s Aphria Slump as Marijuana Faces Regulatory Risk

Shares of Canadian marijuana company Aphria Inc sank on Tuesday, after the operator of the Toronto Stock Exchange said cannabis companies with U.S. interests would come under heightened scrutiny and could be delisted.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc.’s License Transfer Application Approved by the Florida Department of Health, Office of Medical Marijuana Use

TORONTO, Ontario, Sept. 29, 2017 /Weed Wire/ — Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) today announced that the Florida Department of Health, Office of Medical Marijuana Use, approved the transfer of the license to cultivate, process and dispense medical marijuana in the State from Chestnut Hill Tree Farm LLC (“Chestnut”) to Liberty, effective September 28, 2017.

Florida Medical Cannabis Supply Safe in Wake of Hurricane Irma

Florida Medical Cannabis Supply Safe in Wake of Hurricane Irma

On the night of Saturday, Sept. 9, 2017, Hurricane Irma hit the state of Florida, bringing 140-mile-per-hour winds with it. After forcing residents in certain areas to evacuate, it seems as though Hurricane Irma let one thing off the hook —
Florida medical cannabis supply.


Top